Connection

William Haley to Hypertension

Back to Details
This is a "connection" page, showing publications William Haley has written about Hypertension.
William Haley
Connection Strength
2.788
Hypertension
  1. Non-Adherence to Antihypertensive Guidelines in Patients with Asymptomatic Carotid Stenosis. J Stroke Cerebrovasc Dis. 2021 Aug; 30(8):105918.
    View in: PubMed
    Score: 0.392
  2. Ambulatory Blood Pressure Monitoring: Profiles in Chronic Kidney Disease Patients and Utility in Management. Adv Chronic Kidney Dis. 2019 03; 26(2):92-98.
    View in: PubMed
    Score: 0.334
  3. The association between Self-Reported Medication Adherence scores and systolic blood pressure control: a SPRINT baseline data study. J Am Soc Hypertens. 2016 11; 10(11):857-864.e2.
    View in: PubMed
    Score: 0.281
  4. Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial. JAMA Neurol. 2022 04 01; 79(4):380-389.
    View in: PubMed
    Score: 0.103
  5. Is Medication Adherence Predictive of Cardiovascular Outcomes and Blood Pressure Control? The Systolic Blood Pressure Intervention Trial (SPRINT). Am J Hypertens. 2022 02 01; 35(2):182-191.
    View in: PubMed
    Score: 0.102
  6. Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure. Am J Kidney Dis. 2022 05; 79(5):677-687.e1.
    View in: PubMed
    Score: 0.100
  7. Changes in brain functional connectivity and cognition related to white matter lesion burden in hypertensive patients from SPRINT. Neuroradiology. 2021 Jun; 63(6):913-924.
    View in: PubMed
    Score: 0.095
  8. Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial. Stroke. 2020 10; 51(10):2960-2971.
    View in: PubMed
    Score: 0.093
  9. Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants. Am J Nephrol. 2020; 51(10):797-805.
    View in: PubMed
    Score: 0.093
  10. Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria: Post Hoc Analyses from SPRINT. Clin J Am Soc Nephrol. 2020 08 07; 15(8):1121-1128.
    View in: PubMed
    Score: 0.092
  11. Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial. J Am Soc Nephrol. 2020 09; 31(9):2122-2132.
    View in: PubMed
    Score: 0.092
  12. Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT. Hypertension. 2020 03; 75(3):660-667.
    View in: PubMed
    Score: 0.089
  13. Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT. J Am Heart Assoc. 2019 07 16; 8(14):e011706.
    View in: PubMed
    Score: 0.086
  14. Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT. Am J Kidney Dis. 2019 01; 73(1):21-30.
    View in: PubMed
    Score: 0.081
  15. Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension. 2018 06; 71(6):1064-1074.
    View in: PubMed
    Score: 0.079
  16. Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis. 2018 03; 71(3):352-361.
    View in: PubMed
    Score: 0.076
  17. Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort. Diabetes Obes Metab. 2018 03; 20(3):629-637.
    View in: PubMed
    Score: 0.076
  18. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control. Circulation. 2018 01 09; 137(2):134-143.
    View in: PubMed
    Score: 0.076
  19. Effects of Intensive BP Control in CKD. J Am Soc Nephrol. 2017 Sep; 28(9):2812-2823.
    View in: PubMed
    Score: 0.074
  20. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension. 2017 01; 69(1):42-50.
    View in: PubMed
    Score: 0.071
  21. Orthostatic changes in systolic blood pressure among SPRINT participants at baseline. J Am Soc Hypertens. 2016 11; 10(11):847-856.
    View in: PubMed
    Score: 0.070
  22. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged =75 Years: A Randomized Clinical Trial. JAMA. 2016 Jun 28; 315(24):2673-82.
    View in: PubMed
    Score: 0.069
  23. Improving care coordination between nephrology and primary care: a quality improvement initiative using the renal physicians association toolkit. Am J Kidney Dis. 2015 Jan; 65(1):67-79.
    View in: PubMed
    Score: 0.061
  24. Labile hypertension: characteristics of a referred cohort. Clin Exp Hypertens. 2013; 35(3):207-12.
    View in: PubMed
    Score: 0.053
  25. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD. Clin J Am Soc Nephrol. 2020 03 06; 15(3):349-358.
    View in: PubMed
    Score: 0.022
  26. Cognitive Function and Kidney Disease: Baseline Data From the?Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis. 2017 Sep; 70(3):357-367.
    View in: PubMed
    Score: 0.019
  27. Characteristics of 100 consecutive patients presenting with orthostatic hypotension. Mayo Clin Proc. 2004 Jul; 79(7):890-4.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.